An Early Phase 1 Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy: The Omeprazole and Aspirin Polyp Prevention Study
Latest Information Update: 15 Apr 2025
At a glance
- Drugs Aspirin (Primary) ; Omeprazole (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Therapeutic Use
- 02 Jun 2024 Planned End Date changed from 1 Dec 2025 to 1 Jan 2026.
- 02 Jun 2024 Planned primary completion date changed from 1 Jun 2025 to 1 Jul 2025.
- 02 Jun 2024 Planned initiation date changed from 1 May 2024 to 1 Jun 2024.